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Abstract: Hemoglobin is not normally
present in sputum, urine or feces except in
minute amounts. Demonstration of the
presence of hemoglobin in these materials is
an important diagnostic clue that usually
implies bleeding within the respiratory,
urinary or gastroentestinal tract, respectively.

hypoxanthine-aminopterin-thymidine (HAT)

In this work, a hybridoma line secreting
monoclonal antibody (Mab) highly specific for
human hemoglobin A (hHbA) was generated
by fusion of immunized BALB/c mouse splenic
lymphocytes with non-secreting mouse
myeloma cells followed by selection in

sensitivity of the immune test systems based
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Introduction
The development of hybridoma technology by Köhler
and Milstein (1) provided an important opportunity for
the examination of a range of difficult issues. Mabs are
used in in-vitro diagnosis, in radioimmunoassays (RIA),
enzyme-linked
sorbent
assays
(ELISA),
immunocytopathology, and flow cytometry in in-vivo
diagnosis and immunotherapy.
Hemoglobin is the oxygen binding molecule of
vertebrate red blood cells. It is also found in some
invertebrates and in the root nodules of legumes (2).
Hemoglobin is not normally present in sputum, urine,
or feces. The demonstration of the presence of
hemoglobin in these materials is an important diagnostic
clue that usually implies bleeding within the respiratory,
urinary, or gastroentestinal tract. The biochemical tests
for the detection of hemoglobin are dependent on the fact
that heme proteins act as a peroxidase, catalyzing the
reduction of H2O2 to water. This reaction requires a
hydrogen donor (3).
Although benzidine derivatives are presumed to be
carcinogenic, o-tolidine is used in a commercially available
dipstick method (3). The o-tolidine tests can detect as

medium and the screening of culture fluids for
hHb A affinity in ELISA.
The Mab produced by MAM 2/3B6 is highly
specific to hHbA and did not react with
heterologous

hemoglobin

species.

The

on the produced Mab was found to be 0.1
µg/of hHb per ml.
Key Words: Immunodiagnosis, monoclonal
antibody, human hemoglobin, ELISA

little as 2 mg of hemoglobin per deciliter of urine and
100 mg of hemoglobin per 100 g feces, the equivalent of
about 10 red blood cells per µl of urine or 1 ml of blood
per 100 g of feces, respectively (2,3).
A guaiac-based commercial test for fecal occult blood
is less sensitive than the o-tolidine based tests; falsepositive results are therefore very infrequent. In a more
sensitive test for blood in feces, heme-derived dicarboxylporphyrins are extracted from feces and measured
fluorometrically. The procedure is more time consuming
than o-tolidine or guaiac tests and more expensive, but it
is much more specific than other tests for fecal blood. It
does not distinguish between porphyrins derived from
hemoglobin as opposed to those derived from myoglobin.
Consequently, a diet containing no red meat must be
adhered to for three days before the specimen is collected
(2,3).
In this paper, we report the development of a hybrid
cell (MAM/2-3B6) producing a monoclonal antibody
specific to hHbA (β globin chain) for use in specific and
sensitive detection of hHbA avoiding false results due to
cross reactions of the antibody with non-human
hemoglobins.
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Materials and Methods
Preparation of hemolysate
Hemoglobin fractions (hemolysate) from normal
individuals were prepared as described (4) and used for
immunization of BALB/c mice. Red cells obtained from
normal adults were washed three times in normal saline
and lysed by shaking in two volumes of distilled water.
The stroma was removed by vigorously mixing the lysed
cells with one volume of carbon tetrachloride and
centrifuging at 3000xg for 20 min. The clear hemoglobin
solution above the stromal layer, which forms at the
interface with the carbon tetrachloride, had a
concentration of 8-10 gr/dl (4).
Immunization
Eight-week-old BALB/c mice were immunized
subcutaneously with 1 mg hemoglobin emulsified in
complete Freund’s adjuvant (CFA). Two and five weeks
after the initial injection, the animals received
subcutaneous injections of 1 mg hemoglobin emulsified in
incomplete Freund’s adjuvant (IFA). After three weeks’
rest, the animals were given three intravenous injections
of 0.1 mg of hemoglobin on three consecutive days (5).
Fusion
The spleen cells were isolated from the mouse with
the highest anti-hemoglobin antibody titer on day 59 and
were fused with mouse myeloma cells, P3 X 63-Ag8.653
(ATCC CRL 1580), at a ratio of 1:6. The standard fusion,
cloning and subcloning protocols were performed as
described previously (6,7). Polyethylene glycol 4000
(Fluka) was used as the fusion agent.
ELISA
The indirect ELISA method was used to detect
antibody activity in the mouse sera and hybridoma
supernatant (7,8).
In the direct ELISA system, anti-hHbA monoclonal
antibody conjugated to AP was used (9).
The competitive ELISA system was used to detect
hemoglobin in feces. The stool specimen was dipped into
extraction vials containing 1 ng-100 µg human
hemoglobin in 1ml PBS. The vials were closed and shaken
well. The mixtures were incubated for 10 minutes at
room temperature. 100-µl supernatants were mixed with
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200 ng MAM-2/3B6 - AP conjugate and transferred to
ELISA microwells coated with 500 ng human hemoglobin.
The inhibition of coated hemoglobin binding to MAM/23B6 was determined from the results (10). For the
control, 1 ng-100 µg human hemoglobin in 1 ml PBS was
used without the addition of a stool specimen.
Determination of Ig Type
The heavy-chain type of the monoclonal antibody was
determined with an Ig subisotyping kit (Behring
diagnostic).
Purification of Monoclonal Antibody
The antibody was precipitated from the hybridoma
culture supernatant at 40 percent (NH4)2SO4 saturation,
in PBS (150mM K-phospate, pH 7.2) and dialyzed against
the same buffer (11). The mouse monoclonal antibody
was eluted from a Protein G Mab Trap Kit with elution
buffer containing 1M glycine after immediate
neutralization. Monoclonal antibody anti-hemoglobin was
affinity -purified on Eupergit C (12).
Conjugation
0.35 mg of AP (Boehringer Manheim) in 0.035 ml
volume was treated with 0.001ml of 25% glutaraldehyde
solution. After incubation for 50 min at 25ºC, 0.15 mg of
IgG (affinity purified) in potassium phosphate buffer was
added. The mixture was gently stirred for 75 min at
25ºC, then transferred onto a sephacryl 300 (S 300)
(SIGMA) column and the conjugate was eluted with TrisHCl buffer (50 mM pH: 8.0 containing 0.1M NaCl, 1mM
MgCl2, 0.1% Na-azide (w/v)) in fractions of 1ml.
Preparation of Globin Chains
The heme moiety was separated from the globin in
acid-acetone solution. The globin chains were separated
by CM cellulose (CM 52) column chromatography using
urea-phosphate buffer at pH 6-7, the optimum condition
for the separation of globin chains. (4).
Electrophoresis
The hemoglobin was analyzed by SDS-PAGE (13) and
native PAGE (14), followed by transblotting on
polyvinylidene difluoride (PVDF) membrane (15). The
immunoreactivity of the transferred peptides with the
monoclonal antibody MAM-2/3B6 was assayed by
western blotting (16).
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Table 1.

Results

Reactivity of the monoclonal antibody MAM-2/3B6 with
different hemoglobin species and globin chains.

Preparation of anti-hHb
The mice with the highest titer of anti-hHbA antibody
were sacrificed and the spleen cells were used in the
th
fusion. On the 16 day, the culture fluids were tested for
the presence of anti-hHbA by ELISA. Of the original 480
wells, 143 exibited macroscopically visible hybridoma
clones in culture. Only 27 of the 143 produced anti-hHbA
antibodies and MAM-2/3B6 was subjected to three
subcloning steps by limiting dilution.
Characterization of anti-hHbA
The supernatant of the MAM-2/3B6 cells, propagated
in normal culture flasks, and the secreted antibody were
tested for possible cross-reaction with closely related
antigens and also for reaction with globin chains
separated by CM 52 chromatography. The results in
Table 1 show that the mab produced by MAM-2/3B6 did
not react with heterologous hemoglobin species, nor with
the closely related homologous hemoglobin types fetal
hemoglobin (hHbF) and human hemoglobin A2 (hHbA2).
Its reaction with human transferrin was negligible. The
antibody reacted with β-globin as well as (or even slightly
better than) it did with hHbA.

A405

No Antigen (-Ag) control (+Ab)
No antibody (-Ab) control (+Ag)
Mouse hemolysate
Rabbit hemolysate
Horse hemolysate
Bovine hemolysate
Sheep hemolysate
hHbF
hHbA2
Human α globin
Human β globin
hHbA
Human apotransferrin
Human Serum Albumin

0.18
0.19
0.24
0.21
0.28
0.19
0.19
0.30
0.26
0.20
1.71
1.65
0.22
0.24

Table 2.

The Mab was purified from MAM-2/3B6 cell culture
supernatant by ammonium sulphate precipitation and
chromatography on a Protein G mab trap column.
(Fig.1).
The subisotype of MAM-2/3B6 mab was found to be
IgG1 (Table 2).

Subisotype

A405

IgG1
IgG2a
.IgG2b
IgG3
IgM
IgA

0.65
0.17
0.18
0.2
0.16
0.15

A 405

5

Subisotype of MAM-2/3B6 antibody.

stirring, and was then washed and mixed with mab MAM2/3B6 (1.5 mg/ml). The monoclonal antibodies were
eluted with 3.5 M sodium thiocyanate (Fig. 2). The
functions under the A280 and A405 peaks were pooled.

Mab MAM 2/3B6 was antigen-specific affinity-purified
on Eupergit C; 25 mg of hHb was incubated with 200 mg
of Eupergit C for 5 days at room temperature with
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Affinity chromatography elution
profile of the Mab MAM-2/3B6
from Protein G affinity column
(1X1cm). First peak was obtained
using binding buffer (20 mM Naphosphate pH 7.0). IgG fractions
eluted from column with 0.1 M
Glycine HCl pH 2.7 (1ml/10
min/tube).
Fractions
were
neutralized with 1M Tris HCl pH 9.
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Fig. 2.
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Affinity purification of mab MAM2/3B6 on C. 11th-15th fractions
were collected.
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Monoclonal antibody MAM-2/3B6 was conjugated to
alkaline phosphatase as previously reported (16). The
MAM-2/3B6-AP conjugate was purified on a Sephacryl
300 column. The main conjugate peak fractions were
pooled and compared wih regard to specific activity by
ELISA (Fig.3).

Discussion
The aim of this study was to develop a functional
antibody against hHb. The detection of occult blood in
stool can be most useful in the early diagnosis and
treatment of patients with colonic cancer. (17). The early
stages of colorectal polyps and carcinomas are
characterized by the intermittent release of small
amounts of blood. The monitoring of high risk patients
and systematic screening of the population over the age
of 50 using a sensitive method is thus recommended.

Fig.4 shows that the binding of anti-hHbA-AP to
hHbA is directly proportional to the amount added in the
ELISA system. The purified conjugate did not contain free
IgG and AP and did not react.
The hemoglobin in the stool samples was determined
according to competition with the free Hb for binding to
MAM 2/3B6. As shown in Fig. 5, inhibition increased with
hemoglobin concentration.

Most commercial tests are based on the
pseudoperoxidase activity of blood. Unless a strict diet
has been observed during the days before testing, these
tests are affected by a large proportion of false positive
results. Thus, sensitivity is reduced, yielding many false
negative results (17).

The immunoreactivity of MAM-2/3B6 with human
hemoglobin was shown with SDS-PAGE (12%) (Fig. 6).
Fig.7 shows the immunoreactivity of MAM-2/3B6 on
native gel electrophoresis (12%).

In this study, we developed a hybridoma clone, MAM2/3B6, producing antibody highly specific to the human
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Fig. 3.

Determination of main conjugate
peak on S 300 column and its
ELISA activity. The first protein
peak containing fractions (A280)
which contain the purified
conjugate was combined.
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Determination of free hemoglobin inhibition in stool.
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Immunoreactivity of MAM-2/3B6 with human hemoglobin.
A. SDS-PAGE: 1. Marker (67 kD and 25 kD), 2.
Hemoglobin (reduced with βmet and nondenatured), 3.
Hemoglobin (nonreduced with βmet and nondenatured), 4.
Hemoglobin (reduced with βmet and denatured), 5.
Hemoglobin (nonreduced with βmet and denatured). 6.
Marker (44 kD and 13,7 kD). B. Analysis of western
blotting.

hemoglobin β globin chain. The tests performed showed
that the monoclonal antibody MAM-2/3B6 obtained by
hybridoma technology has a high specificity and affinity
(10-11) for human hemoglobin. The results suggest that
this antibody can be used for the immune diagnosis of
occult blood in body fluids and feces by systems like

A
Fig. 7.

5

6

B
Immunoreactivity of MAM-2/3B6 with human hemoglobin
on native gel. A. Native-PAGE: 1. Marker (44 kD) 2.
Marker (67 kD), 3. Hemoglobin (nondenatured), 4. Globin
(nondenatured) 5. Hemoglobin (denatured).

ELISA as other hemoglobin variants do not have the β
globin chain.
In the hHb test of the feces, the subjects did not need
to follow a special diet since MAM-2/3B6 does not crossreact with non-human hemoglobins.
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